Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis.

CONCLUSION: In this large health insurance claims analysis, rapid adoption of PCX, higher long term survival, better amputation free survival, and lower rates of major cardiovascular events were seen after their use for the treatment of CLTI.
PMID: 31926836 [PubMed - as supplied by publisher]

Source: PubMed: Eur J Vasc Endovasc ... - January 7, 2020 Category: Surgery Authors: Behrendt CA, Sedrakyan A, Peters F, Kreutzburg T, Schermerhorn M, Bertges DJ, Larena-Avellaneda A, L'Hoest H, Kölbel T, Debus ES Tags: Eur J Vasc Endovasc Surg Source Type: research